Mino Resigns as CEO of Lumera; HHMI Extends Haussler's Appointment; Deltadot, TheraGenetics Expand Boards; and Others | GenomeWeb
NEW YORK (GenomeWeb News) - Lumera said this week that Thomas Mino has resigned as CEO and from his post on the company’s board of directors. Mino will continue to serve Lumera in a consulting capacity, the company said.
 
Lumera’s board has formed a search committee to find a new CEO. Until then, current board member Joseph Vallner will step in as president and interim CEO.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.